RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Abrogation of postprandial triglyceridemia with dual PPAR alpha/gamma agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study.

Abrogation of postprandial triglyceridemia with dual PPAR alpha/gamma agonist in type 2 diabetes mellitus: a randomized, placebo-controlled study.

Add to Collection
2020 Jul Others Fist_Author_Year_PM

Full Author : ['Rastogi, Ashu', 'Dunbar, Richard L', 'Thacker, Hemant P', 'Bhatt, Jayesh', 'Parmar, Krupi', 'Parmar, Deven V']
Journal Title : Acta diabetologica
Chapter : Section3
Journal Year : 2020
Cited by : Not Available

AIMS: Lowering postprandial lipemia may mitigate cardiovascular risk in patients with diabetic dyslipidemia. This study was aimed to investigate whether saroglitazar suppresses postprandial lipemia in patients with diabetes and dyslipidemia. METHODS: This.....

Keywords : ["dual ppar alphagamma agonist", "type diabetes mellitus", "randomized placebocontrolle study", "postprandial triglyceridemia", "abrogation"]